Company intelligence / Profile preview

The Entourage Effect

Ownership: Private
Development stage: Phase 2

Overview

The Entourage Effect is Australia's fastest-growing alternative medicine wholesaler and distributor, providing distribution services for medicinal cannabis and other alternative medicine brands to pharmacies across Australia[1][3].

Modalities: Medical cannabisAlternative medicine
Industry: Non-Academic Healthcare

Drug pipeline

2 assets

THX-TS01

Phase 2

Indications: Tourette syndrome

1 more asset in the full pipeline.

Request access →

Partnerships

MedReleaf Australia (Aurora Cannabis subsidiary)[5][6]distributes products from brands including Lot 420, Redecan, Tilray Medical, and Broken Coast[6]

Beyond the preview

Go deeper on The Entourage Effect.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The Entourage Effect.

Explore the full profile